Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Leuk Res. 2017 Jun 2;59:110–116. doi: 10.1016/j.leukres.2017.06.001

Figure 2.

Figure 2

Overall survival according to molecular status in [A] PMF and [B] PET/PPV-MF.* Molecular groups with fewer than 10 cases are not shown [PET-MF TN, n=4, median OS = 73 months, and PET-MF MPL, n=7, median OS = 121 months (range, 22–220)].